CPL
GILD icon

Capital & Planning LLC’s Gilead Sciences GILD Stock Holding History

Capital & Planning LLC’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$139 Buy
+1
New +$140 ﹤0.01% 167
2025
Q1 		– Sell
-1
Closed -$92 – 88
2024
Q4 		$92 Buy
+1
New +$90 ﹤0.01% 191

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital & Planning LLC's GILD Position: Q1 2026 in Review

Capital & Planning LLC opened a new position in Gilead Sciences (GILD) in Q1 2026: 1 share worth $139. The stake represents ﹤0.01% of the portfolio and ranks #167 among its holdings. This is a return to the name: Capital & Planning LLC previously reported a position in GILD as recently as Q4 2024.

Capital & Planning LLC first reported a position in GILD in Q4 2024 and has held it in 2 quarters since. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Capital & Planning LLC held 1 share of Gilead Sciences worth $139 as of Q1 2026.
  • Gilead Sciences was a new Capital & Planning LLC position in Q1 2026.
  • Gilead Sciences made up ﹤0.01% of Capital & Planning LLC's portfolio in Q1 2026, its #167 holding.
  • Capital & Planning LLC first reported a position in Gilead Sciences in Q4 2024 and has held it in 2 quarters since.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Capital & Planning LLC's 13F filing for Q1 2026, filed 18 May 2026.